| Lastest Insider Transactions Of Amylyx Pharmaceuticals, Inc. ( AMLX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2024-03-05 | Sell | 4,135 | 18.73 | 77,440 | 2024-03-07 16:05:17 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2024-03-05 | Sell | 4,135 | 18.73 | 77,440 | 2024-03-07 16:05:13 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2024-03-05 | Sell | 1,792 | 18.73 | 33,560 | 2024-03-07 16:05:11 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2024-03-05 | Sell | 1,540 | 18.73 | 28,841 | 2024-03-07 16:05:10 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2024-02-23 | Sell | 2,838 | 18.76 | 53,231 | 2024-02-27 17:59:17 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2024-01-09 | Sell | 5,841 | 16.33 | 95,372 | 2024-01-11 17:11:55 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2024-01-09 | Sell | 2,716 | 16.33 | 44,347 | 2024-01-11 17:11:49 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2024-01-09 | Sell | 5,841 | 16.33 | 95,372 | 2024-01-11 17:10:55 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2024-01-09 | Sell | 2,812 | 16.33 | 45,915 | 2024-01-11 17:04:56 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Olinger Margaret | Chief Commercial Officer | 2023-12-27 | Option Exercise | 25,000 | 0.37 | 9,250 | 2023-12-29 16:07:35 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Firestone Karen | Directior | 2023-12-15 | Buy | 4,000 | 14.97 | 59,880 | 2023-12-19 16:37:26 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2023-11-16 | Option Exercise | 63,694 | 1.57 | 100,000 | 2023-11-20 20:20:39 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-08-23 | Option Exercise | 18,165 | 6.88 | 124,975 | 2023-08-24 16:15:54 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2023-08-15 | Sell | 6,164 | 20.88 | 128,686 | 2023-08-17 16:35:44 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Olinger Margaret | Chief Commercial Officer | 2023-07-12 | Option Exercise | 20,000 | 0.37 | 7,400 | 2023-07-14 16:20:33 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-05-16 | Sell | 32,500 | 26.94 | 875,451 | 2023-05-18 20:54:37 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-05-16 | Option Exercise | 32,500 | 6.88 | 223,600 | 2023-05-18 20:54:37 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-05-15 | Sell | 11,965 | 29.03 | 347,358 | 2023-05-17 16:58:42 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-05-15 | Option Exercise | 11,965 | 5.68 | 67,991 | 2023-05-17 16:58:42 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-04-17 | Sell | 49,579 | 30.54 | 1,513,942 | 2023-04-19 19:45:13 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-04-17 | Option Exercise | 49,579 | 0.99 | 49,058 | 2023-04-19 19:45:13 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-29 | Sell | 29,048 | 30.45 | 884,512 | 2023-03-31 16:05:11 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-27 | Sell | 160,964 | 30.42 | 4,896,561 | 2023-03-29 16:05:31 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-03-16 | Sell | 32,500 | 31.89 | 1,036,459 | 2023-03-24 18:48:19 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-03-16 | Option Exercise | 32,500 | 6.88 | 223,600 | 2023-03-24 18:48:19 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-03-16 | Sell | 54,627 | 31.87 | 1,741,200 | 2023-03-24 18:45:03 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-03-16 | Option Exercise | 49,578 | 2.57 | 127,262 | 2023-03-24 18:45:03 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-21 | Sell | 63,448 | 31.91 | 2,024,495 | 2023-03-23 16:05:14 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2023-03-16 | Sell | 100,000 | 31.86 | 3,186,236 | 2023-03-20 20:31:01 |
| AMLX | Amylyx Pharmaceuticals, Inc. | MILNE GEORGE M JR | Directior | 2023-03-16 | Sell | 35,000 | 31.89 | 1,116,073 | 2023-03-20 20:25:57 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-03-16 | Sell | 54,627 | 31.87 | 1,741,200 | 2023-03-20 20:25:55 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Firestone Karen | Directior | 2023-03-16 | Buy | 1,000 | 31.99 | 31,990 | 2023-03-20 20:22:25 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2023-03-16 | Sell | 100,000 | 31.86 | 3,186,336 | 2023-03-20 20:21:04 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-03-16 | Sell | 32,500 | 31.89 | 1,036,459 | 2023-03-20 20:18:57 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-16 | Sell | 9,122 | 32.55 | 296,921 | 2023-03-17 16:05:09 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-14 | Sell | 220,714 | 33.68 | 7,433,459 | 2023-03-16 16:11:53 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-02 | Sell | 50,000 | 33.75 | 1,687,500 | 2023-03-06 09:10:38 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2023-02-24 | Sell | 3,586 | 34.49 | 123,672 | 2023-02-28 16:42:39 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-02-24 | Sell | 50,000 | 34.73 | 1,736,352 | 2023-02-28 16:06:25 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-02-22 | Sell | 100,000 | 35.78 | 3,578,103 | 2023-02-24 16:13:58 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-01-06 | Sell | 2,034 | 36.30 | 73,831 | 2023-01-10 19:22:45 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2023-01-06 | Sell | 5,968 | 36.30 | 216,629 | 2023-01-10 19:20:58 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-01-06 | Sell | 2,658 | 36.30 | 96,481 | 2023-01-10 19:20:38 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Olinger Margaret | Chief Commercial Officer | 2023-01-06 | Sell | 2,403 | 36.30 | 87,225 | 2023-01-10 19:19:15 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2023-01-06 | Sell | 5,968 | 36.30 | 216,629 | 2023-01-10 19:12:48 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2022-12-30 | Option Exercise | 5,000 | 6.88 | 34,400 | 2023-01-04 21:33:55 |
